Company at a Glance
Price
Infographic
Overview
Sanofi is a leading global pharmaceutical company headquartered in Paris, France. It was founded in 1973 and has a presence in over 170 countries. The company specializes in developing and manufacturing a wide range of prescription drugs and consumer healthcare products.
Sanofi's mission is to provide high-quality, innovative healthcare solutions to improve the lives of people around the world. They focus on four main therapeutic areas: diabetes, cardiovascular diseases, vaccines, and general medicines.
The company has a diverse portfolio of products, including blockbuster drugs such as Lantus (insulin), Plavix (antiplatelet), and Dupixent (eczema treatment). They also have a strong presence in consumer healthcare with popular brands like Allegra, Dulcolax, and Gold Bond.
In addition to their pharmaceutical and consumer healthcare businesses, Sanofi also has a strong commitment to research and development. They have partnerships and collaborations with universities, research institutions, and biotech companies to discover and develop new treatments for a variety of diseases.
Sanofi is committed to sustainability and social responsibility and has several initiatives in place to reduce their environmental impact and give back to the communities where they operate. These include programs for access to medicines in developing countries, environmental protection, and employee volunteer projects.
Overall, Sanofi is a global healthcare company dedicated to improving the lives of people through innovative and high-quality healthcare solutions.
How to explain to a 10 year old kid about the company?
π Want to read more about Sanofi?
Sign up for free
or
log in
β‘ Instantly access "The Checklist Value Investor β A Smarter Way to Pick Stocks" β free!
U2Fub2ZpIG lzIGEgY29t cGFueSB0aG F0IGhlbHBz IHBlb3BsZS BzdGF5IGhl YWx0aHkgYW 5kIGZlZWwg YmV0dGVyIH doZW4gdGhl eSBhcmUgc2 ljay4gVGhl eSBtYWtlIH RoaW5ncyBs aWtlIG1lZG ljaW5lIGFu ZCB2YWNjaW 5lcy4gTWVk aWNpbmUgaG VscHMgcGVv cGxlIGdldC BiZXR0ZXIg ZnJvbSBpbG xuZXNzZXMs IGFuZCB2YW NjaW5lcyBo ZWxwIHByb3 RlY3QgcGVv cGxlIGZyb2 0gZ2V0dGlu ZyBzaWNrIG luIHRoZSBm aXJzdCBwbG FjZS48YnI+ SGVyZeKAmX MgaG93IFNh bm9maSBtYW tlcyBtb25l eTogV2hlbi B0aGV5IGNy ZWF0ZSBuZX cgbWVkaWNp bmVzIGFuZC B2YWNjaW5l cyB0aGF0IH dvcmsgd2Vs bCwgZG9jdG 9ycyBjYW4g cHJlc2NyaW JlIHRoZW0g dG8gcGF0aW VudHMsIGFu ZCBob3NwaX RhbHMgY2Fu IHVzZSB0aG VtIHRvIGhl bHAgc2ljay BwZW9wbGUu IFdoZW4gdG hlc2UgbWVk aWNpbmVzIG FyZSBzb2xk LCBTYW5vZm kgZWFybnMg bW9uZXkuIF RoZXkgYWxz byBtYWtlIG 1vbmV5IGJ5 IHNlbGxpbm cgdGhlaXIg cHJvZHVjdH MgaW4gZGlm ZmVyZW50IG NvdW50cmll cyBhcm91bm QgdGhlIHdv cmxkLCBub3 QganVzdCBp biBvbmUgcG xhY2UuPGJy PlNhbm9maS BpcyBzdWNj ZXNzZnVsIG ZvciBhIGZl dyByZWFzb2 5zLiBGaXJz dCwgdGhleS BoYXZlIGEg bG90IG9mIH NjaWVudGlz dHMgYW5kIH Jlc2VhcmNo ZXJzIHdoby B3b3JrIGhh cmQgdG8gZG lzY292ZXIg bmV3IGFuZC BiZXR0ZXIg bWVkaWNpbm VzLiBUaGV5 IHNwZW5kIG EgbG90IG9m IHRpbWUgYW 5kIG1vbmV5 IHRlc3Rpbm cgdGhlc2Ug bWVkaWNpbm VzIHRvIG1h a2Ugc3VyZS B0aGV5IGFy ZSBzYWZlIG FuZCBlZmZl Y3RpdmUuIF NlY29uZCwg dGhlcmUgYX JlIGFsd2F5 cyBuZXcgaG VhbHRoIGNo YWxsZW5nZX MgYW5kIGRp c2Vhc2VzLC BzbyBwZW9w bGUgd2lsbC BhbHdheXMg bmVlZCBtZW RpY2luZSBh bmQgdmFjY2 luZXMsIHdo aWNoIG1lYW 5zIHRoZXJl IGlzIGEgY2 9uc3RhbnQg ZGVtYW5kIG ZvciB3aGF0 IHRoZXkgY3 JlYXRlLiBM YXN0bHksIH RoZXkgYWxz byB3b3JrIH dpdGggb3Ro ZXIgb3JnYW 5pemF0aW9u cyBhbmQgZ2 92ZXJubWVu dHMgdG8gaG VscCBzcHJl YWQgdGhlaX IgcHJvZHVj dHMgYXJvdW 5kIHRoZSB3 b3JsZC48Yn I+SW4gdGhl IGZ1dHVyZS wgU2Fub2Zp IGlzIGxpa2 VseSB0byBz dGF5IHN1Y2 Nlc3NmdWwg YmVjYXVzZS B0aGV5IGtl ZXAgZGlzY2 92ZXJpbmcg bmV3IHRyZW F0bWVudHMs IGFuZCBhcy Btb3JlIHBl b3BsZSBhcm 91bmQgdGhl IHdvcmxkIG 5lZWQgaGVs cCB3aXRoIG hlYWx0aCBw cm9ibGVtcy wgdGhleSB3 aWxsIGNvbn RpbnVlIHRv IGJlIGltcG 9ydGFudC4g UGx1cywgdG hleSBhcmUg d29ya2luZy BvbiBuZXcg dHlwZXMgb2 YgbWVkaWNp bmVzLCBsaW tlIHRob3Nl IHRoYXQgaG VscCB3aXRo IGxvbmctbG FzdGluZyBk aXNlYXNlcy wgd2hpY2gg bWVhbnMgdG hleSB3aWxs IGFsd2F5cy BoYXZlIHNv bWV0aGluZy B0byBvZmZl ciB0byBoZW xwIG1hbnkg cGVvcGxlLj xicj4=
What is special about the company?
π Want to read more about Sanofi?
Sign up for free
or
log in
π Your free copy of "The Checklist Value Investor β A Smarter Way to Pick Stocks" is waiting
VGhlcmUgYX JlIHNldmVy YWwgdGhpbm dzIHRoYXQg bWF5IGJlIG NvbnNpZGVy ZWQgc3BlY2 lhbCBhYm91 dCB0aGUgU2 Fub2ZpIGNv bXBhbnk6PG JyPjEuIEds b2JhbCBwcm VzZW5jZTog U2Fub2ZpIG lzIGEgbXVs dGluYXRpb2 5hbCBwaGFy bWFjZXV0aW NhbCBjb21w YW55IHdpdG ggYSBnbG9i YWwgcHJlc2 VuY2UgaW4g b3ZlciAxNz AgY291bnRy aWVzLiBUaG lzIGFsbG93 cyB0aGVtIH RvIHJlYWNo IGEgZGl2ZX JzZSByYW5n ZSBvZiBwYX RpZW50cyBh bmQgc2Vydm UgZGl2ZXJz ZSBtZWRpY2 FsIG5lZWRz IGFyb3VuZC B0aGUgd29y bGQuPGJyPj IuIERpdmVy c2lmaWVkIH BvcnRmb2xp bzogU2Fub2 ZpIGhhcyBh IHdlbGwtZG l2ZXJzaWZp ZWQgcG9ydG ZvbGlvLCB3 aXRoIGEgZm 9jdXMgb24g bXVsdGlwbG UgdGhlcmFw ZXV0aWMgYX JlYXMgaW5j bHVkaW5nIG NhcmRpb3Zh c2N1bGFyIG Rpc2Vhc2Vz LCBkaWFiZX Rlcywgb25j b2xvZ3ksIG ltbXVub2xv Z3ksIGFuZC ByYXJlIGRp c2Vhc2VzLi BUaGlzIGhl bHBzIHRoZS Bjb21wYW55 IHdpdGhzdG FuZCB0aGUg aW1wYWN0IG 9mIHNoaWZ0 cyBpbiBtYX JrZXQgZGVt YW5kIGZvci BwYXJ0aWN1 bGFyIGRydW dzLjxicj4z LiBJbm5vdm F0aW9uIGFu ZCByZXNlYX JjaDogU2Fu b2ZpIGlzIG NvbW1pdHRl ZCB0byByZX NlYXJjaCBh bmQgaW5ub3 ZhdGlvbiwg aW52ZXN0aW 5nIGhlYXZp bHkgaW4gcm VzZWFyY2gg YW5kIGRldm Vsb3BtZW50 IChSJkQpIH RvIGJyaW5n IGxpZmUtc2 F2aW5nIGFu ZCBsaWZlLW VuaGFuY2lu ZyBtZWRpY2 luZXMgdG8g cGF0aWVudH MuIEluIDIw MTksIHRoZS Bjb21wYW55 IGludmVzdG VkIG92ZXIg NiBiaWxsaW 9uIGV1cm9z IGluIFImRC 48YnI+NC4g UGF0aWVudC 1jZW50cmlj IGFwcHJvYW NoOiBTYW5v ZmkgcGxhY2 VzIGEgc3Ry b25nIGVtcG hhc2lzIG9u IHVuZGVyc3 RhbmRpbmcg YW5kIGFkZH Jlc3Npbmcg dGhlIG5lZW RzIG9mIHBh dGllbnRzLi BUaGUgY29t cGFueSB1c2 VzIGEgcGF0 aWVudC1jZW 50cmljIGFw cHJvYWNoIG luIGRldmVs b3Bpbmcgbm V3IGRydWdz IGFuZCBpbX Byb3Zpbmcg ZXhpc3Rpbm cgdHJlYXRt ZW50cy48Yn I+NS4gQ29y cG9yYXRlIH NvY2lhbCBy ZXNwb25zaW JpbGl0eTog U2Fub2ZpIG lzIGNvbW1p dHRlZCB0by Bjb3Jwb3Jh dGUgc29jaW FsIHJlc3Bv bnNpYmlsaX R5IGluaXRp YXRpdmVzLC BpbmNsdWRp bmcgcHJvdm lkaW5nIGFj Y2VzcyB0by BtZWRpY2lu ZXMgYW5kIG hlYWx0aGNh cmUgZm9yIH VuZGVyc2Vy dmVkIHBvcH VsYXRpb25z LCByZWR1Y2 luZyB0aGVp ciBlbnZpcm 9ubWVudGFs IGltcGFjdC wgYW5kIHBy b21vdGluZy BkaXZlcnNp dHkgYW5kIG luY2x1c2lv biBpbiB0aG VpciB3b3Jr Zm9yY2UuPG JyPjYuIFN0 cm9uZyBwYX J0bmVyc2hp cHM6IFNhbm 9maSBoYXMg c3Ryb25nIH BhcnRuZXJz aGlwcyB3aX RoIG90aGVy IHBoYXJtYW NldXRpY2Fs IGNvbXBhbm llcywgYWNh ZGVtaWMgaW 5zdGl0dXRp b25zLCBhbm QgaGVhbHRo Y2FyZSBvcm dhbml6YXRp b25zLiBUaG lzIGhlbHBz IHRoZW0gY2 9sbGFib3Jh dGUgb24gcm VzZWFyY2gg YW5kIGRldm Vsb3BtZW50 IGVmZm9ydH MsIGFuZCBi cmluZyBpbm 5vdmF0aXZl IHRyZWF0bW VudHMgdG8g dGhlIG1hcm tldC48YnI+ Ny4gRW1wbG 95ZWUgZGV2 ZWxvcG1lbn Q6IFNhbm9m aSBwcmlvcm l0aXplcyBl bXBsb3llZS BkZXZlbG9w bWVudCBhbm Qgd2VsbC1i ZWluZywgb2 ZmZXJpbmcg YSByYW5nZS BvZiBkZXZl bG9wbWVudC Bwcm9ncmFt cywgZGl2ZX JzaXR5IGFu ZCBpbmNsdX Npb24gaW5p dGlhdGl2ZX MsIGFuZCBi ZW5lZml0cy B0byBzdXBw b3J0IHRoZW lyIGVtcGxv eWVlcy48Yn I+T3ZlcmFs bCwgU2Fub2 ZpIGlzIGEg d2VsbC1lc3 RhYmxpc2hl ZCBhbmQgcm VzcGVjdGVk IHBoYXJtYW NldXRpY2Fs IGNvbXBhbn kgd2l0aCBh IHN0cm9uZy Bmb2N1cyBv biByZXNlYX JjaCwgaW5u b3ZhdGlvbi wgYW5kIHBh dGllbnQtY2 VudHJpYyBh cHByb2FjaG VzIHRvIGlt cHJvdmUgdG hlIGxpdmVz IG9mIHBhdG llbnRzIGFy b3VuZCB0aG Ugd29ybGQu
What the company's business model?
π Want to read more about Sanofi?
Sign up for free
or
log in
π Unlock our free guide: "The Checklist Value Investor β A Smarter Way to Pick Stocks"
U2Fub2ZpIG lzIGEgZ2xv YmFsIGJpb3 BoYXJtYWNl dXRpY2FsIG NvbXBhbnkg dGhhdCBmb2 N1c2VzIG9u IHJlc2Vhcm NoLCBkZXZl bG9wbWVudC wgcHJvZHVj dGlvbiwgYW 5kIG1hcmtl dGluZyBvZi Bpbm5vdmF0 aXZlIGhlYW x0aGNhcmUg c29sdXRpb2 5zLiBJdHMg YnVzaW5lc3 MgbW9kZWwg aXMgY2VudG VyZWQgYXJv dW5kIGZvdX Iga2V5IGFy ZWFzOjxicj 4xLiBSZXNl YXJjaCBhbm QgRGV2ZWxv cG1lbnQ6IF Nhbm9maSBp bnZlc3RzIG hlYXZpbHkg aW4gcmVzZW FyY2ggYW5k IGRldmVsb3 BtZW50IHRv IGRpc2Nvdm VyIGFuZCBk ZXZlbG9wIG 5ldyBtZWRp Y2luZXMgYW 5kIHZhY2Np bmVzIGZvci B2YXJpb3Vz IGRpc2Vhc2 VzIGFuZCBj b25kaXRpb2 5zLiBUaGlz IGluY2x1ZG VzIGNvbGxh Ym9yYXRpb2 5zIHdpdGgg b3RoZXIgY2 9tcGFuaWVz LCBhY2FkZW 1pYyBpbnN0 aXR1dGlvbn MsIGFuZCBn b3Zlcm5tZW 50cyB0byBh ZHZhbmNlIG l0cyByZXNl YXJjaCBlZm ZvcnRzLjxi cj4yLiBQcm 9kdWN0aW9u IGFuZCBNYW 51ZmFjdHVy aW5nOiBTYW 5vZmkgaGFz IGEgc3Ryb2 5nIHdvcmxk d2lkZSBtYW 51ZmFjdHVy aW5nIGFuZC BzdXBwbHkg Y2hhaW4gbm V0d29yaywg d2l0aCBvdm VyIDQwIHBy b2R1Y3Rpb2 4gc2l0ZXMg aW4gdmFyaW 91cyBjb3Vu dHJpZXMuIF RoaXMgZW5h YmxlcyB0aG UgY29tcGFu eSB0byBlbn N1cmUgYSBz dGVhZHkgc3 VwcGx5IG9m IGl0cyBwcm 9kdWN0cyB0 byBtZWV0IH RoZSBkZW1h bmQgb2YgcG F0aWVudHMg YW5kIGhlYW x0aGNhcmUg cHJvdmlkZX JzLjxicj4z LiBNYXJrZX RpbmcgYW5k IFNhbGVzOi BPbmNlIGEg bmV3IHByb2 R1Y3QgaXMg ZGV2ZWxvcG VkIGFuZCBh cHByb3ZlZC Bmb3IgY29t bWVyY2lhbG l6YXRpb24s IFNhbm9maS B1dGlsaXpl cyB2YXJpb3 VzIG1hcmtl dGluZyBhbm Qgc2FsZXMg c3RyYXRlZ2 llcyB0byBw cm9tb3RlIG FuZCBkaXN0 cmlidXRlIG l0cyBwcm9k dWN0cyBnbG 9iYWxseS4g VGhpcyBpbm NsdWRlcyBw YXJ0bmVyaW 5nIHdpdGgg aGVhbHRoY2 FyZSBwcm92 aWRlcnMsIH BoYXJtYWNp ZXMsIGFuZC BvdGhlciBj b21wYW5pZX MgdG8gcmVh Y2ggYSB3aW RlciBjdXN0 b21lciBiYX NlLjxicj40 LiBEaXZlcn NpZmllZCBQ b3J0Zm9saW 86IFNhbm9m aSdzIGJ1c2 luZXNzIG1v ZGVsIGFsc2 8gaW5jbHVk ZXMgYSBkaX ZlcnNlIHBv cnRmb2xpby BvZiBvdmVy LXRoZS1jb3 VudGVyIChP VEMpIHByb2 R1Y3RzLCBn ZW5lcmljcy wgYW5kIGFu aW1hbCBoZW FsdGggcHJv ZHVjdHMuIF RoaXMgaGVs cHMgdGhlIG NvbXBhbnkg bWl0aWdhdG Ugcmlza3Mg YW5kIGdlbm VyYXRlIHJl dmVudWUgZn JvbSB2YXJp b3VzIHNlZ2 1lbnRzIG9m IHRoZSBoZW FsdGhjYXJl IG1hcmtldC 48YnI+T3Zl cmFsbCwgU2 Fub2ZpJ3Mg YnVzaW5lc3 MgbW9kZWwg aXMgZm9jdX NlZCBvbiBk ZWxpdmVyaW 5nIGlubm92 YXRpdmUgaG VhbHRoY2Fy ZSBzb2x1dG lvbnMgdG8g aW1wcm92ZS B0aGUgbGl2 ZXMgb2YgcG F0aWVudHMg d29ybGR3aW RlLiBJdCBh aW1zIHRvIG FjaGlldmUg bG9uZy10ZX JtIGdyb3d0 aCBhbmQgcH JvZml0YWJp bGl0eSBieS Bjb250aW51 b3VzbHkgaW 52ZXN0aW5n IGluIHJlc2 VhcmNoIGFu ZCBkZXZlbG 9wbWVudCwg ZXhwYW5kaW 5nIGl0cyBw cm9kdWN0IH BvcnRmb2xp bywgYW5kIG 1haW50YWlu aW5nIGEgc3 Ryb25nIGds b2JhbCBwcm VzZW5jZS4=
Is AI a threat?
AI does pose certain material threats to companies like Sanofi, particularly in the pharmaceutical and healthcare sectors. Here are some potential threats related to substitution, disintermediation, and margin pressure:
1. Substitution: AI technologies can potentially lead to the development of new treatments or methods that could substitute for existing Sanofi products. For example, advancements in personalized medicine and AI-driven drug discovery could result in alternative therapeutic options that outperform traditional pharmaceuticals.
2. Disintermediation: AI could enable a more direct connection between patients and healthcare solutions, bypassing traditional pharmaceutical models. For instance, AI-powered telemedicine platforms might offer diagnostic tools and treatment recommendations that reduce the reliance on established pharmaceutical intermediaries, thereby affecting the business dynamics that Sanofi operates within.
3. Margin Pressure: As AI tools become more pervasive in drug development and personalized medicine, the costs associated with bringing new drugs to market could decrease. This increased efficiency might lead to intensified competition, exerting downward pressure on prices and margins for established products. Companies like Sanofi may need to invest more in AI capabilities to maintain a competitive edge, potentially increasing operational costs.
In summary, while AI brings opportunities for innovation and improved healthcare outcomes, it also introduces challenges that could impact Sanofiβs market position and profitability. The company will need to adapt strategically to address these risks effectively.
Sensitivity to interest rates
Sanofiβs earnings, cash flow, and valuation are sensitive to changes in interest rates in several ways:
1. Earnings: Increased interest rates can lead to higher borrowing costs for companies. If Sanofi has variable-rate debt, its interest expenses would rise, potentially reducing net income. Higher rates can also decrease consumer spending, affecting pharmaceutical sales if patients opt for less expensive alternatives or forego treatments.
2. Cash Flow: Cash flow is impacted primarily through financing costs and operational performance. As interest rates rise, Sanofi may face higher costs if refinancing debt or issuing new debt. Additionally, if higher rates lead to economic slowdowns, this can affect overall cash inflows from operations due to decreased sales.
3. Valuation: The present value of future cash flows, which forms the basis of discounted cash flow valuation, is sensitive to the discount rate (often influenced by interest rates). As rates rise, the discount rate increases, potentially lowering the present value of Sanofiβs future cash flows. This can lead to a decrease in stock valuation, as investors may require higher return rates in response to the prevailing interest rate environment.
In summary, while Sanofi operates in a stable industry, increases in interest rates can negatively impact its earnings, cash flows, and overall valuation due to higher costs, reduced consumer spending, and changes in the discount rate applied to future cash flows.
Resilience to the future changes
π Want to read more about Sanofi?
Sign up for free
or
log in
π Donβt miss "The Checklist Value Investor β A Smarter Way to Pick Stocks" β free!
T25lIHJlYW xpc3RpYyBz Y2VuYXJpby B0aGF0IGNv dWxkIHBlcm 1hbmVudGx5 IGltcGFpci BTYW5vZmni gJlzIGVjb2 5vbWljcyBv dmVyIHRoZS BuZXh0IDPi gJM1IHllYX JzIGlzIGEg c2lnbmlmaW NhbnQgYW5k IHByb2xvbm dlZCBmYWls dXJlIGluIH RoZSBkZXZl bG9wbWVudC BvZiBpdHMg cGlwZWxpbm UgZHJ1Z3Ms IHBhcnRpY3 VsYXJseSBp biBoaWdoLX ZhbHVlIHRo ZXJhcGV1dG ljIGFyZWFz IHN1Y2ggYX Mgb25jb2xv Z3ksIGltbX Vub2xvZ3ks IGFuZCBkaW FiZXRlcy4g SWYgU2Fub2 ZpIHdlcmUg dG8gZmFjZS ByZXBlYXRl ZCBjbGluaW NhbCB0cmlh bCBmYWlsdX JlcyBmb3Ig a2V5IGRydW cgY2FuZGlk YXRlcywgZX NwZWNpYWxs eSB0aG9zZS BleHBlY3Rl ZCB0byBkcm l2ZSBmdXR1 cmUgZ3Jvd3 RoLCB0aGUg b3V0Y29tZS Bjb3VsZCBz ZXZlcmVseS BpbXBhY3Qg aXRzIGZpbm FuY2lhbCBo ZWFsdGguPG JyPkluIHRo aXMgc2Nlbm FyaW8sIFNh bm9maeKAmX MgbWFyZ2lu cyB3b3VsZC BsaWtlbHkg ZGVjcmVhc2 UgYXMgdGhl IGNvbXBhbn kgd291bGQg bmVlZCB0by ByZWRpcmVj dCBmdW5kcy Bmcm9tIHBy b2ZpdGFibG UgcHJvZHVj dHMgdG8gY2 9udGludWUg aW52ZXN0aW 5nIGluIHJl c2VhcmNoIG FuZCBkZXZl bG9wbWVudC B3aXRob3V0 IGdlbmVyYX RpbmcgZXhw ZWN0ZWQgcm V0dXJucy4g VGhlIGFic2 VuY2Ugb2Yg bmV3IHByb2 R1Y3RzIGNv dWxkIGxlYW QgdG8gYSBy ZWxpYW5jZS BvbiBleGlz dGluZyBkcn Vncywgd2hp Y2ggbWF5IG ZhY2UgcHJp Y2UgcHJlc3 N1cmVzIGFu ZCBtYXJrZX Qgc2hhcmUg ZXJvc2lvbi BvdmVyIHRp bWUuPGJyPk Nhc2ggZmxv dyB3b3VsZC BhbHNvIGJl IG5lZ2F0aX ZlbHkgYWZm ZWN0ZWQgZH VlIHRvIGxv d2VyIHJldm VudWVzIGZy b20gc2FsZX MuIFRoZSBj b21wYW554o CZcyBvcGVy YXRpb25hbC BjYXNoIGZs b3cgY291bG QgYmVjb21l IGNvbnN0cm FpbmVkLCBs ZWFkaW5nIH RvIGNoYWxs ZW5nZXMgaW 4gZnVuZGlu ZyBvbmdvaW 5nIG9wZXJh dGlvbnMgYW 5kIHJlc2Vh cmNoLiBXaX Rob3V0IG5l dyBwcm9kdW N0cyBjb250 cmlidXRpbm cgdG8gcmV2 ZW51ZSwgU2 Fub2ZpIG1p Z2h0IGFsc2 8gYmUgZm9y Y2VkIHRvIG N1dCBjb3N0 cywgd2hpY2 ggY291bGQg aW5jbHVkZS BsYXlvZmZz IG9yIHJlZH VjdGlvbnMg aW4gbWFya2 V0aW5nIGFu ZCBSJmFtcD tEIHNwZW5k aW5nLiBIb3 dldmVyLCB0 aGVzZSBtZW FzdXJlcyBt YXkgbm90IG JlIHN1ZmZp Y2llbnQgdG 8gb2Zmc2V0 IHRoZSByZX ZlbnVlIHNo b3J0ZmFsbC 48YnI+T24g dGhlIGJhbG FuY2Ugc2hl ZXQsIHRoZS BpbmNyZWFz ZWQgcmVsaW FuY2Ugb24g ZGVidCBjb3 VsZCBiZWNv bWUgZXZpZG VudCBhcyBT YW5vZmkgbW F5IHNlZWsg ZXh0ZXJuYW wgZmluYW5j aW5nIHRvIG 1haW50YWlu IG9wZXJhdG lvbnMgYW5k IGZ1bmQgaX RzIFImYW1w O0QgZWZmb3 J0cyBkdXJp bmcgdGhpcy Bkb3dudHVy bi4gVGhpcy Bjb3VsZCBs ZWFkIHRvIG EgZGVjbGlu ZSBpbiBjcm VkaXQgcmF0 aW5ncyBhbm QgaW5jcmVh c2VkIGJvcn Jvd2luZyBj b3N0cy4gQW RkaXRpb25h bGx5LCBpZi B0aGUgYmFs YW5jZSBzaG VldCByZWZs ZWN0cyBhIG hpZ2hlciBy YXRpbyBvZi BkZWJ0IHRv IGVxdWl0eS wgaXQgY291 bGQgc2lnbm FsIHRvIGlu dmVzdG9ycy Bjb25jZXJu cyBhYm91dC BmaW5hbmNp YWwgc3RhYm lsaXR5Ljxi cj5PdmVyYW xsLCBpZiB0 aGlzIHNjZW 5hcmlvIHdl cmUgdG8gdW 5mb2xkLCBp bnZlc3Rvcn MgY291bGQg cmVhY3Qgbm VnYXRpdmVs eSwgbGVhZG luZyB0byBh IGRlY2xpbm UgaW4gc3Rv Y2sgcHJpY2 VzLCByZWR1 Y2VkIG1hcm tldCBjYXBp dGFsaXphdG lvbiwgYW5k IGEgcG90ZW 50aWFsIGxv c3Mgb2YgY2 9uZmlkZW5j ZSBpbiB0aG UgY29tcGFu eeKAmXMgbG 9uZy10ZXJt IHByb3NwZW N0cy4gT3Zl cmFsbCwgU2 Fub2ZpIHdv dWxkIGZhY2 UgYSBjaGFs bGVuZ2luZy BlY29ub21p YyBlbnZpcm 9ubWVudCB0 aGF0IGNvdW xkIHRha2Ug eWVhcnMgdG 8gcmVjb3Zl ciBmcm9tLC B3aXRoIGxh c3RpbmcgaW 1wbGljYXRp b25zIGZvci BpdHMgZmlu YW5jaWFsIG 1ldHJpY3Mu PGJyPg==
Interesting facts about the company
π Want to read more about Sanofi?
Sign up for free
or
log in
π‘ Learn smarter stock picks with "The Checklist Value Investor β A Smarter Way to Pick Stocks"
CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvWn FnaEQwRDdX NnFURktFSW hFMmMud2Vi cCIgYWx0PS JTYW5vZmki IHRpdGxlPS JTYW5vZmki ICBjbGFzcz 0iaW1nLWZs dWlkIiBoZW lnaHQ9NTAg d2lkdGg9NT AgbG9hZGlu Zz0nbGF6eS cgc3R5bGU9 J2JvcmRlci 1yYWRpdXM6 IDZweDsnPg oKICAgICAg ICAgICAgIC AgICAgICA8 ZGl2IHN0eW xlPSdmbGV4 OiAxOyB0ZX h0LWFsaWdu OiBjZW50ZX I7IG1hcmdp bi1sZWZ0Oi A1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPHAgc3R5 bGU9J2Zvbn Qtc2l6ZTog MjZweDsgY2 9sb3I6ICMz MzM7IG1hcm dpbi1ib3R0 b206IDE1cH g7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIPCfk4gg V2FudCB0by ByZWFkIG1v cmUgYWJvdX QgU2Fub2Zp PwogICAgIC AgICAgICAg ICAgICAgIC AgICA8L3A+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8YSBo cmVmPSdpbm RleC5waHA/ cGFnZT1zaW dudXAnIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGJhY2 tncm91bmQt Y29sb3I6IC MwMDdCRkY7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBj b2xvcjogI2 ZmZjsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH ggMjBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGJv cmRlci1yYW RpdXM6IDVw eDsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IHRleHQtZG Vjb3JhdGlv bjogbm9uZT sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG ZvbnQtd2Vp Z2h0OiBib2 xkOwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgbWFyZ2lu LXJpZ2h0Oi AxMHB4Owog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgdHJh bnNpdGlvbj ogYmFja2dy b3VuZC1jb2 xvciAwLjNz IGVhc2U7Jw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgb2 5tb3VzZW92 ZXI9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA1Nm IzIicKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG9ubW91 c2VvdXQ9J3 RoaXMuc3R5 bGUuYmFja2 dyb3VuZENv bG9yPSIjMD A3QkZGIic+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBT aWduIHVwIG ZvciBmcmVl CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvYT4K CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxzcGFu IHN0eWxlPS dtYXJnaW46 IDAgOHB4Oy Bjb2xvcjog IzU1NTsnPm 9yPC9zcGFu PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9bG 9naW4nIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGNvbG 9yOiAjMDA3 QkZGOwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgdGV4dC 1kZWNvcmF0 aW9uOiB1bm RlcmxpbmU7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBm b250LXdlaW dodDogNTAw Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBsb2cgaW 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9hPg oKCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxwIH N0eWxlPSdt YXJnaW4tdG 9wOiAxNXB4 OyBmb250LX NpemU6IDEz cHg7IGZvbn Qtd2VpZ2h0 OiBib2xkOy Bjb2xvcjog I2QzMmYyZj snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Ag8J+TmiBZ b3VyIGZyZW UgY29weSBv ZiA8aT4iVG hlIENoZWNr bGlzdCBWYW x1ZSBJbnZl c3RvciDigJ QgQSBTbWFy dGVyIFdheS B0byBQaWNr IFN0b2Nrcy I8L2k+IGlz IHdhaXRpbm cKICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9wPg oKICAgICAg ICAgICAgIC AgICAgICAg ICAgPCEtLQ ogICAgICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdt YXJnaW4tdG 9wOiAxMnB4 OyBmb250LX NpemU6IDEz cHg7IGNvbG 9yOiAjNDQ0 Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBTaWduIH VwIG5vdyBh bmQgZ2V0IG 91ciBmcmVl IGVCb29rIA ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgPG I+VGhlIENo ZWNrbGlzdC BWYWx1ZSBJ bnZlc3Rvci DigJQgQSBT bWFydGVyIF dheSB0byBQ aWNrIFN0b2 NrczwvYj4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9kaXY+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIC0tPgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8IS0tCiAg ICAgICAgIC AgICAgICAg ICAgICAgID xkaXYgc3R5 bGU9J21hcm dpbi10b3A6 IDE2cHg7IG ZvbnQtc2l6 ZTogMTRweD sgY29sb3I6 ICM0NDQ7IG ZvbnQtZmFt aWx5OiAtYX BwbGUtc3lz dGVtLCBCbG lua01hY1N5 c3RlbUZvbn QsIFNlZ29l IFVJLCBSb2 JvdG8sIEhl bHZldGljYS BOZXVlLCBz YW5zLXNlcm lmOyBsaW5l LWhlaWdodD ogMS42Oyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBI YXZlIHlvdS BoZWFyZCBh Ym91dCBvdX Igc2hvcnQg PHN0cm9uZy BzdHlsZT0n Zm9udC13ZW lnaHQ6IDYw MDsnPkRhaW x5IFZpZGVv IE5ld3NsZX R0ZXI8L3N0 cm9uZz4/Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICA8YS BocmVmPSdo dHRwczovL3 d3dy5pbnNp Z2h0ZnVsdm FsdWUuY29t L25ld3NsZX R0ZXIucGhw JyB0YXJnZX Q9J19ibGFu aycgc3R5bG U9J2NvbG9y OiAjMDA3Qk ZGOyB0ZXh0 LWRlY29yYX Rpb246IG5v bmU7IGZvbn Qtd2VpZ2h0 OiA1MDA7IG 1hcmdpbi1s ZWZ0OiA2cH g7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBG aW5kIG91dC Btb3JlCiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICA8L2E+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvZGl2 PgogICAgIC AgICAgICAg ICAgICAgIC AgICAtLT4K ICAgICAgIC AgICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC AgICAgIDwv ZGl2PgogIC AgICAgICAg ICA8L2Rpdj 4KICAgICAg ICAgICAgCi AgICAgICAg CiAgICAgIC AgPHNwYW4g Y2xhc3M9J2 JsdXJyZWQt dGV4dCc+Ci AgICAgICAg ICAgIFUyRn ViMlpwSUcg bHpJR0VnWj J4diBZbUZz SUdobFlXIH gwYUdOaGNt VWcgWTI5dG NHRnVlUyBC b1pXRmtjWF ZoIGNuUmxj bVZrSUcgbH VJRkJoY21s eiBMQ0JHY2 1GdVkyIFVz SUd0dWIzZH UgSUdadmNp QnBkSCBNZ2 QybGtaU0J5 IFlXNW5aU0 J2WmkgQndh R0Z5YldGai BaWFYwYVdO aGJDIEJ3Y2 05a2RXTjAg Y3lCaGJtUW dkbSBGalky bHVaWE11IE lFaGxjbVVn WVggSmxJSE 52YldVZyBh VzUwWlhKbG MzIFJwYm1j Z1ptRmogZE hNZ1lXSnZk WCBRZ1UyRn ViMlpwIE9q eGljajR4TG kgQklhWE4w YjNKNSBPaU JUWVc1dlpt IGtnZDJGek lHWnYgY20x bFpDQnBiaS BBeU1EQTBJ SGRvIFpXNG dkR2hsSUUg WnlaVzVqYU NCdyBhR0Z5 YldGalpYIF YwYVdOaGJD QmogYjIxd1 lXNTVJRiBO aGJtOW1hUz FUIGVXNTBh TU9wYkcgRm lieUJ0WlhK biBaV1FnZD JsMGFDIEJC ZG1WdWRHbH ogTENCaGJt OTBhRyBWeU lHMWhhbTl5 IElIQm9ZWE p0WVcgTmxk WFJwWTJGcy BJR1pwY20w dUlGIFJvWl NCeWIyOTAg Y3lCdlppQn BkSCBNZ2NI SmxaR1ZqIF pYTnpiM0ln WTIgOXRjR0 Z1YVdWeiBJ R05oYmlCaV pTIEIwY21G alpXUWcgWW 1GamF5QjBi eSBCMGFHVW daV0Z5IGJI a2dNakIwYU MgQmpaVzUw ZFhKNSBMan hpY2o0eUxp IEJIYkc5aV lXd2cgVUhK bGMyVnVZMi BVNklGTmhi bTltIGFTQn ZjR1Z5WVgg UmxjeUJwYm lCdCBiM0ps SUhSb1lXID RnTVRBd0lH TnYgZFc1MG NtbGxjeSBC aGJtUWdhR0 Z6IElHRWdj MmxuYm0gbG 1hV05oYm5R ZyBjSEpsYz JWdVkyIFVn YVc0Z1pXMW wgY21kcGJt Y2diVyBGeW EyVjBjeXdn IFkyOXVkSE pwWW4gVjBh VzVuSUdFZy BjM1ZpYzNS aGJuIFJwWV d3Z2NHOXkg ZEdsdmJpQn ZaaSBCcGRI TWdjbVYyIF pXNTFaUzQ4 WW4gSStNeT RnVW1WeiBa V0Z5WTJnZ1 lXIDVrSUVS bGRtVnMgYj NCdFpXNTBP aSBCVFlXNX ZabWtnIGFX NTJaWE4wY3 kgQm9aV0Yy YVd4NSBJR2 x1SUhKbGMy IFZoY21Ob0 lHRnUgWkNC a1pYWmxiRy A5d2JXVnVk Q3dnIFptOW pkWE5wYm0g Y2diMjRnWV hKbCBZWE1n YzNWamFDIE JoY3lCa2FX RmkgWlhSbG N5d2diMiA1 amIyeHZaM2 tzIElHbHRi WFZ1YjIgeH ZaM2tzSUdG dSBaQ0IyWV dOamFXIDVs Y3k0Z1ZHaG wgSUdOdmJY QmhibiBrZ1 lXbHRjeUIw IGJ5QmtaWF psYkcgOXdJ R2x1Ym05Mi BZWFJwZG1V Z2RHIGhsY2 1Gd2FXVnog SUdGdVpDQj BjbSBWaGRH MWxiblJ6IE lIUnZJR0Zr WkggSmxjM0 1nZFc1dCBa WFFnYldWa2 FXIE5oYkNC dVpXVmsgY3 k0OFluSStO QyA0Z1ZtRm pZMmx1IFpY TTZJRk5oYm 0gOW1hU0Jw Y3lCdiBibV VnYjJZZ2RH IGhsSUd4aG NtZGwgYzNR Z2RtRmpZMi BsdVpTQnRZ VzUxIFptRm pkSFZ5Wlgg SnpJR2x1SU hSbyBaU0Iz YjNKc1pDID RnU1hRZ2NI SnYgWkhWal pYTWdZUyBC aWNtOWhaQ0 J5IFlXNW5a U0J2WmkgQj JZV05qYVc1 bCBjeUJtYj NJZ1pHIGx6 WldGelpYTW cgYzNWamFD QmhjeSBCcG JtWnNkV1Z1 IGVtRXNJSE J2YkcgbHZM Q0JoYm1RZy BiV1Z1YVc1 bmFYIFJwY3 lCMGFISnYg ZFdkb0lHbD BjeSBCemRX SnphV1JwIF lYSjVMQ0JU WVcgNXZabW tnVUdGeiBk R1YxY2k0OF luIEkrTlM0 Z1JHbGggWW 1WMFpYTWdR MiBGeVpUb2 dVMkZ1IGIy WnBJR2hoY3 kgQmhJSE4w Y205dSBaeU J3YjNKMFpt IDlzYVc4Z2 FXNGcgWkds aFltVjBaWC BNZ2JXRnVZ V2RsIGJXVn VkQ3dnZDIg bDBhQ0JoSU haaCBjbWxs ZEhrZ2IyIF lnYldWa2FX TmggZEdsdm JuTWdZVyA1 a0lHMWxaR2 xqIFlXd2da R1YyYVcgTm xjeUJoYVcx bCBaQ0JoZE NCcGJYIEJ5 YjNacGJtY2 cgZEdobElH eHBkbSBWek lHOW1JSEJs IGIzQnNaU0 IzYVggUm9J R1JwWVdKbC BkR1Z6TGp4 aWNqIDQyTG lCRGIyMXQg YVhSdFpXNT BJSCBSdklG TjFjM1JoIG FXNWhZbWxz YVggUjVPaU JUWVc1diBa bWtnYVhNZ1 kyIDl0Ylds MGRHVmsgSU hSdklITjFj MyBSaGFXNW hZbWxzIGFY UjVJR0Z1Wk MgQkRiM0p3 YjNKaCBkR1 VnVTI5amFX IEZzSUZKbG MzQnYgYm5O cFltbHNhWC BSNUlDaERV MUlwIElHbH VhWFJwWVgg UnBkbVZ6TE NCbSBiMk4x YzJsdVp5IE J2YmlCcGJY QnkgYjNacG JtY2daMiB4 dlltRnNJR2 hsIFlXeDBh Q3dnY20gVm tkV05wYm1j ZyBaVzUyYV hKdmJtIDFs Ym5SaGJDQn AgYlhCaFkz UXNJRyBGdV pDQndjbTl0 IGIzUnBibW NnWVcgTmpa WE56SUhSdi BJR2hsWVd4 MGFHIE5oY2 1VdVBHSnkg UGpjdUlFTl BWayBsRUxU RTVJRkpsIG MzQnZibk5s T2kgQkVkWE pwYm1jZyBk R2hsSUVOUF ZrIGxFTFRF NUlIQmggYm 1SbGJXbGpM QyBCVFlXNX ZabWtnIFky OXNiR0ZpYj MgSmhkR1Zr SUhkcCBkR2 dnYjNSb1pY IElnWTI5dG NHRnUgYVdW eklHRnVaQy BCdmNtZGhi bWw2IFlYUn BiMjV6SUgg UnZJSEpoY0 dsayBiSGtn WkdWMlpXIH h2Y0NCMllX TmogYVc1bG N5QmhibSBR Z2RISmxZWF J0IFpXNTBj eXdnYUcgbG 5hR3hwWjJo MCBhVzVuSU dsMGN5IEJo WjJsc2FYUj UgSUdGdVpD QmpiMiAxdG FYUnRaVzUw IElIUnZJSE IxWW0geHBZ eUJvWldGcy BkR2d1UEdK eVBqIGd1SU VWdGNHeHYg ZVdWbElFSm hjMiBVNklG Um9aU0JqIG IyMXdZVzU1 SUcgVnRjR3 h2ZVhNZyBk R1Z1Y3lCdl ppIEIwYUc5 MWMyRnUgWk hNZ2IyWWdj RyBWdmNHeG xJSGR2IGNt eGtkMmxrWl Mgd2djbVZt YkdWaiBkR2 x1WnlCcGRI IE1nYzJsNl pTQmggYm1R Z1pYaDBaVy A1emFYWmxJ Rzl3IFpYSm hkR2x2Ym4g TWdhVzRnZE dobCBJSEJv WVhKdFlXIE 5sZFhScFky RnMgSUdsdV pIVnpkSCBK NUxqeGljaj Q1IExpQlFZ WEowYm0gVn ljMmhwY0hN NiBJRk5oYm 05bWFTIEJ2 Wm5SbGJpQm wgYm1kaFoy VnpJRyBsdU lIQmhjblJ1 IFpYSnphR2 x3Y3kgQmhi bVFnWTI5cy BiR0ZpYjNK aGRHIGx2Ym 5NZ2QybDAg YUNCdmRHaG xjaSBCdmNt ZGhibWw2IF lYUnBiMjV6 TEMgQnBibU 5zZFdScCBi bWNnWW1sdm RHIFZqYUNC bWFYSnQgY3 l3Z2RHOGda VyA1b1lXNW paU0JwIGRI TWdjbVZ6Wl cgRnlZMmdn WTJGdyBZV0 pwYkdsMGFX IFZ6SUdGdV pDQmkgY21s dVp5QnBibS A1dmRtRjBh WFpsIElIQn liMlIxWTMg UnpJSFJ2SU cxaCBjbXRs ZEM0OFluIE krTVRBdUlF RmogWTJWem N5QjBieSBC TlpXUnBZMm x1IFpUb2dV MkZ1YjIgWn BJR2x6SUds dSBkbTlzZG 1Wa0lHIGx1 SUhaaGNtbH YgZFhNZ2FX NXBkRyBsaG RHbDJaWE1n IFlXbHRaV1 FnWVggUWdh VzF3Y205Mi BhVzVuSUdG alkyIFZ6Y3 lCMGJ5QnQg WldScFkyRj BhVyA5dWN5 QnBiaUJzIG IzZGxjaTFw Ym0gTnZiV1 VnWTI5MSBi blJ5YVdWek lIIFJvY205 MVoyZ2cgWk c5dVlYUnBi MiA1ekxDQn dZWEowIGJt VnljMmhwY0 ggTXNJR0Z1 WkNCaCBabV p2Y21SaFlt IHhsSUhCeW FXTnAgYm1j Z2MzUnlZWC BSbFoybGxj eTQ4IFluSS tWR2hsYzIg VWdabUZqZE hNZyBhV3hz ZFhOMGNtIE YwWlNCVFlX NXYgWm1uaW dKbHpJSCBK dmJHVWdZWE 1nIFlTQnJa WGtnY0cgeG hlV1Z5SUds dSBJSFJvWl NCbmJHIDlp WVd3Z2FHVm ggYkhSb1ky RnlaUyBCc1 lXNWtjMk5o IGNHVWdZVz VrSUcgbDBj eUJqYjIxdC BhWFJ0Wlc1 MElIIFJ2SU dsdWJtOTIg WVhScGIyNG dZVyA1a0lI QjFZbXhwIF l5Qm9aV0Zz ZEcgZ3VQR0 p5UGc9PQog ICAgICAgID wvc3Bhbj4K ICAgICAgIC AKICAgICAg ICA=
See Company Q&A
π Get full analytics about Sanofi
Sign up for free
or
log in
π₯ Get our free eBook now: "The Checklist Value Investor β A Smarter Way to Pick Stocks"